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ABSTRACT
Objective We aimed to understand the role of the 
transcriptional co- factor Yes- associated protein (Yap) 
in the molecular pathway underpinning the pathogenic 
transformation of synovial fibroblasts (SF) in rheumatoid 
arthritis (RA) to become invasive and cause joint 
destruction.
Methods Synovium from patients with RA and mice 
with antigen- induced arthritis (AIA) was analysed 
by immunostaining and qRT- PCR. SF were targeted 
using Pdgfrα-CreER and Gdf5- Cre mice, crossed with 
fluorescent reporters for cell tracing and Yap- flox mice 
for conditional Yap ablation. Fibroblast phenotypes were 
analysed by flow cytometry, and arthritis severity was 
assessed by histology. Yap activation was detected using 
Yap–Tead reporter cells and Yap–Snail interaction by 
proximity ligation assay. SF invasiveness was analysed 
using matrigel- coated transwells.
Results Yap, its binding partner Snail and downstream 
target connective tissue growth factor were upregulated 
in hyperplastic human RA and in mouse AIA synovium, 
with Yap detected in SF but not macrophages. Lineage 
tracing showed polyclonal expansion of Pdgfrα- 
expressing SF during AIA, with predominant expansion 
of the Gdf5- lineage SF subpopulation descending from 
the embryonic joint interzone. Gdf5- lineage SF showed 
increased expression of Yap and adopted an erosive 
phenotype (podoplanin+Thy- 1 cell surface antigen−), 
invading cartilage and bone. Conditional ablation of Yap 
in Gdf5- lineage cells or Pdgfrα- expressing fibroblasts 
ameliorated AIA. Interleukin (IL)- 6, but not tumour 
necrosis factor alpha (TNF-α) or IL- 1β, Jak- dependently 
activated Yap and induced Yap–Snail interaction. 
SF invasiveness induced by IL- 6 stimulation or Snail 
overexpression was prevented by Yap knockdown, 
showing a critical role for Yap in SF transformation in RA.
Conclusions Our findings uncover the IL- 6–Yap–Snail 
signalling axis in pathogenic SF in inflammatory arthritis.
INTRODUCTION
Rheumatoid arthritis (RA) is a common immune- 
mediated chronic inflammatory disease causing joint 
damage and deformities. Current treatment consists 
of synthetic and biological disease- modifying anti-
rheumatic drugs aimed at systemic immunosuppres-
sion. Nonetheless, some patients fail to respond to 
treatments, and joint damage progression can still 
occur despite clinical remission.1
A hallmark of RA pathology is synovitis, causing 
the synovium to thicken and form a pannus that 
invades cartilage and bone, driven by pathogenic 
transformation and proliferation of fibroblasts 
with infiltration of inflammatory/immune cells. 
A recent study reported two distinct subsets of 
synovial fibroblasts (SF), immune effector fibro-
blasts expressing podoplanin (Pdpn) and Thy- 1 
cell surface antigen (Thy1) found in the sub- lining 
synovial tissue and promoting inflammation, and 
destructive Pdpn+Thy1− fibroblasts in the lining 
layer mediating cartilage and bone damage.2
Cell lineage tracing studies have revealed that 
the adult synovium consists of ontogenetically 
diverse fibroblast subsets. One subset, the Gdf5- 
lineage cells, descend from the Gdf5- expressing 
joint interzone cells in the embryo.3–5 Previously, 
we have shown that these Gdf5- lineage cells 
include the SF in the lining as well as a subset of 
SF in the sublining.5 6 The remaining SF are of 
unknown embryonic origin. It is not known how 
Key messages
What is already known about this subject?
 ► Synovial fibroblasts (SF) are key drivers of 
rheumatoid arthritis (RA) pathogenesis; 
however, the SF lineages involved and the 
molecular mechanisms underpinning their 
pathogenic transformation are incompletely 
understood.
What does this study add?
 ► This study shows that Gdf5- lineage SF, 
defined by their ontogenic derivation from 
the joint interzone, are the key pathogenic 
SF in inflammatory arthritis. Mechanistically, 
interleukin (IL)- 6 signals via Jak to activate Yes- 
associated protein (Yap), which forms a complex 
with Snail to drive the invasiveness of SF, and 
selective targeting of Yap in Gdf5- lineage SF 
ameliorates inflammatory arthritis.
How might this impact on clinical practice or 
future developments?
 ► This study supports the targeting of IL- 6 and 
Jak in RA, not only for immunosuppression but 
also to directly control the Yap–Snail- mediated 
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the ontogenetically defined SF subsets relate to the subsets iden-
tified by Pdpn and Thy1 expression.
The synovial pannus is a tumour- like structure resulting in part 
from uncontrolled fibroblast expansion. Increased activity of the 
transcriptional cofactor Yes- associated protein (Yap) is known to 
cause tissue overgrowth in multiple tissues and organs through 
stimulating cell proliferation.7–13 In addition, Yap promotes cell 
motility and invasion in cancer cells.14–16 We demonstrated that 
Yap promotes proliferation of fibroblast- like mesenchymal cells17 
and that increased Yap activity in Gdf5- lineage cells underpins 
synovial lining hyperplasia following acute joint surface injury 
in mice.5
The role of Yap in immune- mediated inflammatory arthritis 
and the signalling mechanisms that link Yap activity to the 
pathogenic transformation of SF await clarification. A reduced 
severity in the K/BxN serum- transfer arthritis model in mice 
was reported after treatment with the small molecule verte-
porfin,18 a non- specific inhibitor of Yap activity. Although the 
mechanism was not investigated, it was suggested that the bene-
ficial effect was through reduced Yap activity in SF.18 However, 
it cannot be excluded that the effects of verteporfin were Yap- 
independent.19 20 Furthermore, verteporfin was reported to 
ameliorate antigen- induced arthritis (AIA) in rabbits by inducing 
apoptosis of inflammatory cells.21
Here, we show that Yap is highly expressed by SF in both 
human RA and mouse AIA and that conditional genetic abla-
tion of Yap in SF ameliorates AIA. Mechanistically, Yap is Jak- 
dependently activated by interleukin (IL)- 6, a key inflammatory 
cytokine in RA, and forms a complex with the transcription 
factor Snail to drive the SF invasive phenotype. Our findings 
identify the IL- 6–Yap–Snail signalling axis as a fibroblast- specific 
therapeutic target in RA synovitis.
METHODS
Materials and methods are available in the online supplemental 
information file.
RESULTS
Yap is upregulated in human rheumatoid and mouse immune-
mediated synovitis
YAP was upregulated in the hyperplastic compared with quies-
cent lining of human RA synovium (p=0.0003, figure 1A), 
and this was accompanied by upregulation of the transcription 
factor SNAIL (p=0.0003), and the YAP and SNAIL downstream 
target gene connective tissue growth factor (CTGF) (p=0.0078, 
figure 1A), a known pathogenic effector in RA.22 YAP was 
expressed by CD55+ fibroblasts and not by CD68+ macro-
phages (figure 1B). YAP mRNA expression levels correlated 
non- significantly with the expression of SNAIL (p=0.083) and 
significantly with the expression of YAP downstream targets 
CTGF (p=0.024) and GP130 (p=0.001, figure 1C), a trans-
membrane protein required for IL- 6 signalling.23
Analysis of mouse AIA synovium confirmed the upregula-
tion of Yap (p<0.0001, figure 2A), Snail (p=0.0022, figure 2B) 
and Ctgf (p=0.0003, figure 2C) during synovitis. High Yap 
expression was observed in fibroblast- like cells throughout the 
synovium and along the periosteal surface, extending into the 
underlying marrow space at sites of erosive damage (figure 2A 
and online supplemental figure 1a).
Gdf5-lineage Yap-expressing SF are predominant in arthritis
Next, we used genetic cell- labelling and tracing models to 
map fibroblast populations in synovitis. To trace individual 
fibroblasts, we used Pdgfrα-CreER;R26- Confetti mice (see online 
supplemental table 1 for transgenic mouse lines used in the 
study), in which tamoxifen administration activates CreER in 
cells expressing the pan- fibroblast marker Pdgfrα, resulting in 
stochastic expression of one of four fluorescent proteins.6 Anal-
ysis of cyan fluorescent protein (CFP), yellow fluorescent protein 
(YFP) and red fluorescent protein (RFP) expression (green fluo-
rescent protein (GFP) was rarely detected and was omitted from 
analysis) 6 days after AIA induction revealed extensive expan-
sion of Pdgfrα- traced cells in synovium. Multiple small clus-
ters of monochromatic cells were interspersed throughout the 
synovium, indicating polyclonal cell expansion (figure 3A,B).
We previously showed that a subset of Pdgfrα- expressing 
cells in the adult synovium originates from the Gdf5- 
expressing embryonic joint interzone.5 6 These Gdf5- lineage 
SF are mostly found in the synovial lining but also include a 
subset of the SF in the sublining.5 To determine the involve-
ment of the Gdf5- lineage SF in synovitis, we induced AIA in 
Gdf5- Cre;Tom;Pdgfrα-H2BGFP mice and administered BrdU 
to label proliferating cells. In these mice, Cre is expressed and 
permanently switches on Tom expression in cells of the joint 
interzone and all their progeny, while Cre is not active in 
the adult knee.24–26 In addition, Pdgfrα- expressing fibroblasts 
are identified by long- lived nuclear GFP. In control knees, 
Gdf5- lineage SF (ie, Tom+GFP+ cells) were mostly quies-
cent and located predominantly in the synovial lining, while 
other SF (ie, Tom- GFP+ cells) were found throughout the 
synovium (figure 3C,D). In contrast, Gdf5- lineage SF exten-
sively proliferated and infiltrated the entire synovium in the 
AIA knee (figure 3C,D), increasing 4.2±0.6- fold (mean±SD, 
n=5, p<0.001) and constituting the dominant SF lineage in 
the inflamed synovium (figure 3E). A concomitant increase in 
the unlabelled cell population (ie, Tom−GFP− cells) reflects 
the infiltration and expansion of immune cells during syno-
vitis (figure 3E). GFP and Yap co- detection confirmed Yap 
expression by SF in both the synovial lining and along the 
periosteal surface (figure 3F), and Yap expression along the 
bone surface, including at sites of erosion, correlated with 
the presence of Gdf5- lineage cells (online supplemental 
figure 1).
A recent study reported Pdpn+Thy1+ SF to be immunomod-
ulatory and Pdpn+Thy1− SF to be erosive in inflammatory 
arthritis.3 Hence, we investigated the expression of Pdpn and 
Thy1 in the ontogenetically defined SF subsets. While Gdf5- 
lineage SF included both Pdpn+Thy1+ and Pdpn+Thy1− 
phenotypic subsets, we observed a striking increase in the 
percentage of Gdf5- lineage SF with a Pdpn+Thy1− (erosive) 
phenotype during AIA, as compared with control knees 
(p=0.00005, figure 4A and online supplemental figure 2). 
In contrast, the other SF adopted primarily a Pdpn+Thy1+ 
(immunomodulatory) phenotype in response to AIA (p=0.0014, 
figure 4B and online supplemental figure 2).
To determine whether Yap controls the capacity of SF to 
remodel and invade extracellular matrix, we used a matrigel- 
coated Boyden transwell assay.27 DsiRNA- mediated knock-
down of Yap in SF from AIA mice reduced their invasive ability 
(p=0.006, figure 4C). Notably, knockdown of the Yap paralog, 
Taz, did not affect mouse SF invasiveness (online supplemental 
figure 3). In human RA- SF, reduced invasiveness was observed 
after simultaneous knockdown of YAP and TAZ (p=0.011, 
figure 4D).
Altogether, these data show extensive proliferation and 
expansion of Yap- expressing SF throughout the synovium in AIA 
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subset in immune- mediated synovitis, with Yap being required 
for SF invasiveness in vitro.
Conditional ablation of Yap in SF ameliorates inflammatory 
arthritis
To determine the role of Yap in Gdf5- lineage SF in the patho-
physiology of inflammatory arthritis, we conditionally ablated 
Yap in Gdf5- lineage cells and induced AIA. A Cre- inducible Tom 
reporter was crossed into the model, allowing detection of Yap 
conditional KO (cKO) target cells. Immunostaining of synovium 
showed a significant decrease in Yap expression in the cKO mice 
(p<0.0001, figure 5A). The efficiency of Yap cKO was further 
confirmed at mRNA level by qRT- PCR of sorted cells (p<0.001), 
which moreover revealed a significantly higher expression of Yap 
in the Gdf5- lineage SF compared with other SF after 7 days of 
AIA (p=0.004; figure 5B and online supplemental figure 4), 
further supporting a key role for Yap in the Gdf5- lineage AIA- SF.
Nine days after arthritis induction, we observed signif-
icant decreases in synovial lining hyperplasia (p<0.001), 
immune infiltrates in synovium (p=0.026) and erosions at 
the joint margins (p=0.002), and a non- significant trend 
towards decreased cellular exudate, resulting in an overall 
arthritis score of 4.9 (95% CI 4.2 to 5.6, n=22) in the cKO 
mice, compared with 6.5 (95% CI 5.9 to 7.0, n=24) in Yap 
Figure 1 YAP, SNAIL and CTGF are upregulated in hyperplastic rheumatoid arthritis synovium. (A) Immunohistochemical detection of YAP, SNAIL 
and CTGF in quiescent and hyperplastic areas of human RA synovium (YAP n=7, SNAIL n=7, and CTGF n=6). Haematoxylin counterstain is shown in 
blue. Scale bars: 20 µm. For isotype negative control stainings, see online supplemental figure 10a–c. Graphs indicate protein expression in quiescent 
(Q) and hyperplastic (H) synovium based on immunohistochemistry (IHC) staining intensity, with lines and error bars indicating mean±SD (n=6–7). 
P values indicate statistical significance using an unpaired two- tailed t- test. (B) Expression of YAP (magenta), the SF marker CD55 (cyan) and the 
macrophage marker CD68 (yellow) in human RA synovium (n=4). DAPI (4′,6- diamidino- 2- phenylindole) nuclear counterstain is shown in blue. The 
same image is shown three times with different channels overlaid, for clarity. Scale bars: 20 µm. For isotype negative control stainings, see online 
supplemental figure 10d. (C) Correlation between YAP gene expression and expression of SNAIL, CTGF or GP130 in RA synovial biopsies (n=10) as 
determined by qRT- PCR. P values indicate results of Pearson’s correlation test and R2 values the square of the correlation coefficient. CTGF, connective 
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WT mice (p=0.002; figure 5C,D). Despite the decrease in 
arthritis severity in vivo and diminished cell proliferation 
after Yap KO in vitro (p=0.023) (online supplemental figure 
5), extensive expansion of Gdf5- lineage cells in synovium 
during AIA was observed in both Yap WT (p<0.001) and 
Yap cKO mice (p<0.001, figure 5E). Accordingly, using BrdU 
labelling, we detected proliferation of Gdf5- lineage cells 
throughout the synovium in Yap cKO mice at 3 and 6 days 
after AIA induction (figure 5F). These data indicate that Yap 
is largely dispensable for SF proliferation but required for 
SF- mediated disease activity in AIA.
Next, we investigated the effects of conditional Yap abla-
tion on the expression of key catabolic and inflammatory 
mediators by qRT- PCR analysis of Tom+ Gdf5- lineage SF 
purified from AIA mice. Compared with Gdf5- lineage SF 
of Yap WT mice, the Gdf5- lineage SF from Yap cKO mice 
displayed reduced expression levels of critical enzymes medi-
ating SF invasiveness, including Mmp9 (p=0.048), Mmp13 
(p=0.044) and Mmp14 (p=0.012),28–30 as well as the inflam-
matory cytokine IL- 34 (p=0.011) (figure 5G). These data 
point to a role for Yap in mediating critical arthritogenic 
effects of SF that contribute to erosive damage and inflam-
mation in AIA.
In RA, erosive damage to bone is caused by increased osteo-
clastic bone resorption, driven in part by pro- osteoclastogenic 
factors produced by the SF.31 Staining for the osteoclast marker 
TRAP revealed a decreased number of TRAP+ cells along the 
femoral periosteal surface in female Yap cKO mice compared 
with Yap WT controls after AIA (p=0.015; figure 5H and online 
supplemental figure 6), while no significant difference was 
observed in the number of TRAP+ cells at endosteal surfaces 
of the femoral epiphysis (online supplemental figure 6). Accord-
ingly, microCT analysis showed no difference in the trabecular 
bone loss in the tibial epiphysis between Yap WT and Yap cKO 
mice in response to AIA (online supplemental figure 7). Together, 
these data suggest a role for Yap in SF in stimulating local osteo-
clast development in female mice.
Next, we sought to validate these data using a conditional 
tamoxifen- inducible (ci) KO model in which Yap is ablated 
in the SF of the adult knee, using Pdgfrα-CreER as driver. 
Immunodetection of Yap in tissue sections confirmed Yap 
ciKO (figure 6A,B), although with lower efficiency than 
Gdf5- Cre- driven Yap cKO (figure 5A). Nonetheless, we again 
observed a decrease in synovial lining hyperplasia (p=0.013) 
and arthritis score (p=0.0496) compared with Yap WT mice 
(figure 6C,D).
Figure 2 Yap, Snail and Ctgf are upregulated in inflammatory arthritis in mice. (A–C) Immunohistochemical detection of Yap (A), Snail (B) and 
Ctgf (C) in mouse synovium 6 days after AIA induction (n=5; 2 male mice, 3 female mice, 11–13 weeks). Contralateral knee served as control. 
Haematoxylin counterstain is shown in blue. Boxed areas on the left are shown at higher magnification on the right. Arrow (A) indicates Yap- 
expressing cells penetrating through the bone into the underlying marrow space. Scale bars: 20 µm. For isotype negative control stainings, see online 
supplemental figure 10f–h. Graphs indicate protein expression in synovium based on IHC staining intensity, with lines and error bars indicating 
mean±SD (n=5). P values indicate statistical significance using an unpaired two- tailed t- test. AIA, antigen- induced arthritis; A, articular cartilage; B, 
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Together, these findings indicate that Yap has crucial functions 
in pathogenic SF to promote inflammation and joint destruction, 
and demonstrate amelioration following its selective targeting in 
SF in inflammatory arthritis.
IL-6 activates Yap through Jak and induces Yap–Snail 
interaction in SF to drive their invasiveness
To assess the ability of key inflammatory cytokines to activate 
Yap, we used a Yap–Tead reporter construct,32 modified to drive 
GFP expression following stable lentiviral transduction (online 
supplemental figure 8). We detected selective Yap activation 
by IL- 6/sIL6R (p<0.001), while TNF-α or IL- 1β had no effect 
(figure 7A). Baricitinib, a selective Jak1/2 inhibitor, prevented 
the IL- 6/sIL6R- induced activation of Yap (p<0.001, figure 7B), 
as well as phosphorylation of Stat3 (figure 7C), indicating that 
IL- 6- induced Yap activation requires Jak signalling. IL- 6/sIL6R 
stimulation did not increase Yap mRNA expression at least after 
24 hours (figure 7D), indicating that its effect may be mediated 
Figure 3 Pdgfrα- expressing Gdf5- lineage cells expand during inflammatory arthritis. (A,B) Detection of Pdgfrα- traced cells, marked by expression 
of CFP, YFP or RFP, in synovium of Pdgfrα-CreER;Confetti mice induced with tamoxifen from 8 weeks of age prior to AIA induction and analysed after 
6 days of AIA (n=3; 3 male mice, 14–15 weeks). Contralateral knee served as control. (A) Cells labelled by CFP (blue), YFP (yellow) and RFP (red) in 
synovium. TO- PRO- 3 (TP3) nuclear counterstain is shown in grey. (B) Numbers of CFP, YFP and RFP- labelled cells per mm length of synovium. P values 
indicate statistical significance based on two- way ANOVA with Tukey’s post- test after log transformation (n=3). (C–F) Gdf5- Cre;Tom;Pdgfrα-H2BGFP 
mice 6 days after AIA induction (n=5; 2 male mice, 3 female mice, 11–13 weeks). Mice received bromodeoxyuridine (BrdU) to label proliferating cells 
from arthritis induction until the end. (C,D) Expansion of Tom- labelled Gdf5- lineage cells (red) in synovium during AIA, co- staining for (C) GFP (green), 
indicative of Pdgfrα expression (arrowheads indicate Tom+GFP+ cells; arrows indicate Tom- GFP+ cells), or (D) the BrdU proliferation label (green; 
arrowheads indicate Tom+BrdU+ cells). Consecutive tissue sections are shown. For isotype negative control stainings, see online supplemental figure 
10i,j. (E) Numbers of Tom- labelled and GFP- labelled cells per mm length of synovium. P values indicate statistical significance based on two- way 
ANOVA with Tukey’s post- test after log- transformation (n=5). (F) Detection of Yap (red) in GFP- expressing cells (green) in synovial lining (arrowheads) 
and along the periosteal surface (arrows). Scale bars: 20 µm. For isotype negative control stainings, see online supplemental figure 10k. Lines and 
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through post- transcriptional mechanisms. Yap knockdown 
prevented IL- 6/sIL6R- induced invasiveness of normal mouse SF 
(figure 7E), showing that IL- 6 signals via Yap to promote inva-
sion. An IL- 6/sIL6R complex was used in these experiments, 
since SF do not express the IL- 6R (online supplemental figure 
9) and rely on sIL6R, normally produced by immune cells, to 
activate IL- 6 trans- signalling via gp130.33
Since the transcription factor Snail, previously reported to be 
involved in TNF-α-mediated SF activation in RA,34 was upreg-
ulated alongside Yap during RA and AIA synovitis (figures 1A 
and 2B), we investigated the functional relationship between 
Snail and Yap. Snail overexpression increased SF invasiveness 
(p=0.022), and this was prevented by simultaneous knockdown 
of Yap (p=0.027, figure 7F), demonstrating that Snail requires 
Yap to drive SF invasion. Using a proximity ligation assay, we 
found that treatment of mouse SF or human RA- SF with IL- 6/
sIL6R induced the formation of Yap–Snail complexes, similar to 
what is seen after Yap overexpression in mouse SF (figure 7G,H). 
Taken together, these data indicate that IL- 6 trans- signalling in 
SF activates Yap through Jak and increases Yap–Snail interaction 
to promote invasiveness.
DISCUSSION
SF are key cells in RA that sustain inflammation and induce 
tissue damage, but the molecular mechanisms underlying these 
functional characteristics remain to be fully elucidated. Here, 
we report that ablation of Yap in SF ameliorates immune- 
mediated inflammatory arthritis in vivo and show that IL- 6 
increases Yap activity through Jak signalling and promotes 
interaction of Yap and Snail to drive the pathogenic behaviour 
of SF.
Figure 4 Phenotypic analysis of SF in inflammatory arthritis. (A,B) Freshly isolated cells from knees of adult Gdf5- Cre;Tom;Pdgfrα-H2BGFP mice 
6 days after AIA induction (n=6; 5 male mice and one female mouse, 11–14 weeks, pooled data from two experiments) were analysed by flow 
cytometry for the expression of Pdpn and Thy1 within (A) the Gdf5- lineage Pdgfrα- expressing cells (Tom+GFP+) and (B) the remaining Pdgfrα- 
expressing cells (Tom- GFP+). The contralateral knees served as controls. Graphs show the percentage of cells expressing Pdpn with or without 
coexpression of Thy1. P values indicate statistical significance based on unpaired two- tailed t- test after log transformation. For gating strategy and 
staining controls, see online supplemental figure 2. (C) Yap KD decreased AIA- SF invasiveness through matrigel in a transwell assay. Dots are colour- 
coded to indicate different experiments (n=5 for Yap expression, n=6 for cell invasion) using cells from three different mice for DsiRNA#1 (circles), 
and from a fourth mouse for DsiRNA#2 (squares). P values indicate results of two- tailed paired Student’s t- test. (D) YAP/TAZ KD decreased human 
RA- SF invasiveness through matrigel in a transwell assay. Dots are colour- coded to indicate independent experiments using cells from different donors 
(n=3). P values indicate results of two- tailed paired Student’s t- test. AIA, antigen- induced arthritis; KD, knockdown; Pdpn, podoplanin; RA, rheumatoid 
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In a previous study using the K/BxN serum- transfer mouse 
model of inflammatory arthritis and mice engrafted with carti-
lage and RA- SF, treatment with the non- specific Yap inhibitor 
verteporfin was shown to reduce arthritis severity and carti-
lage invasion by RA- SF, respectively.18 However, verteporfin 
exhibits Yap- independent cytostatic and cytotoxic effects and 
was previously shown to ameliorate AIA by inducing immune 
cell apoptosis.19–21 Additionally, Yap is highly expressed by 
endothelium and known to regulate endothelial cell prolif-
eration, migration and survival.35 Indeed, Yap was recently 
reported to mediate synovial angiogenesis in AIA mice, with 
verteporfin shown to reduce angiogenesis and synovitis.35 
Figure 5 Ablation of Yap in Gdf5- lineage cells reduces inflammatory arthritis severity. AIA was induced in one knee of Yap WT or Yap cKO mice, 
with contralateral knee serving as control, and mice were analysed after 3 or 6 days (F), 7 days (B,G) or 9 days (A,C–E,H). See online supplemental 
table 2 for mouse genotypes, sex, age and exclusions. (A) Yap expression in inflamed synovium detected by IHC. Images show mice with highest 
arthritis score in their group. Scale bars: 50 µm. P value: unpaired two- tailed t- test after log transformation (WT: n=24; cKO: n=22; five experiments). 
(B) Yap mRNA expression detected by qRT- PCR in fluorescence- activated cell sorting (FACS)- sorted SF from AIA knees of Yap WT (n=4) and Yap cKO 
mice (n=3–4; 1 Yap cKO Tom- Pdgfrα+ sorted sample was excluded from analysis due to very low cell yield). P values indicate results of two- way 
analysis of variance with Tukey’s post- test after log transformation. (C,D) H&E staining and histological scoring of arthritis severity. Images show 
matched control and AIA knees from mice with arthritis scores (WT: 6.33; cKO: 4.66) close to their group average. Scale bars: 200 µm. P values: Mann- 
Whitney U test (WT: n=24; cKO: n=22; five experiments). (E) Tom+ Gdf5- lineage cells in synovium detected by IHC. Images are from the same mice as 
in (C). Scale bars: 50 µm. Graph shows Tom+ cells per millimetre length of synovium. P values: Kruskal- Wallis test with Dunn’s post- test (WT: n=18; 
cKO: n=22; five experiments). (F) Immunofluorescent detection of BrdU (green) in Tom+ Gdf5- lineage cells (red) in the synovium of Yap cKO mice at 3 
(n=5) or 6 days (n=3) after AIA induction. Scale bars: 20 µm. (G) Expression of Mmps and cytokines detected by qRT- PCR in Gdf5- lineage cells FACS- 
sorted from knees of Yap WT (n=4) or Yap cKO (n=4) mice. P values: unpaired two- tailed t- test after log transformation. (H) TRAP+ cells along the 
medial and lateral femoral periosteal surface of female mice. P value: unpaired two- tailed t- test (WT: n=15; cKO: n=14; five experiments). Boxed areas 
in images on the left are shown at higher magnification on the right. For isotype negative control stainings, see online supplemental figure 10e,f,j. For 
FACS strategy, see online supplemental figure 4. Data on graphs are shown as mean±95% CI (A, D, E, H) or mean±SD (B, G). AIA, antigen- induced 
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Here, we unequivocally show, by conditional ablation of Yap 
in SF using two different mouse models, a specific role for 
Yap in driving the pathological behaviour of SF in inflamma-
tory arthritis. The recent demonstration of additional roles 
for Yap in promoting synovial angiogenesis further supports 
the possible therapeutic benefits of targeting Yap in RA 
synovitis.35
We previously reported that increased Yap activity in Gdf5- 
lineage SF drives synovial lining hyperplasia in a traumatic joint 
surface injury model in mice.5 In the present study, we show 
that ablation of Yap in Gdf5- lineage SF reduced not only syno-
vial lining hyperplasia but also immune infiltration and erosive 
damage in inflammatory arthritis. Decreased synovial lining 
hyperplasia in AIA was also observed when Yap was knocked 
out in fibroblasts in adult mice, showing this is not a result of 
developmental defects resulting from Yap KO.
Although the upstream regulators of Yap activity are likely 
to be context- dependent, we uncover a hitherto unappreciated 
molecular link between Jak- mediated IL- 6 signalling, pivotal in 
RA pathogenesis, and the Yap- mediated invasive SF phenotype. 
While IL- 6 treatment of SF enhanced invasive behaviour, Yap 
silencing completely prevented the IL- 6- induced SF invasion. 
JAK inhibition with baricitinib was shown to abrogate cytokine- 
induced invasive behaviour of SF.36 Together, this suggests that 
JAK inhibitors such as baricitinib could ameliorate RA disease in 
part by modulating YAP activity in SF.
SF, which do not express the IL- 6R, undergo pro- inflammatory 
sIL6R- mediated trans- signalling, facilitated by cell surface 
expression of GP130.33 We showed a strong correlation between 
YAP and GP130 expression in human RA synovium, in accor-
dance with evidence that YAP upregulates GP130 expression 
in an autoregulatory loop,23 indicating that YAP plays a role 
in amplifying IL- 6 signalling and maintaining invasiveness in 
RA- SF. YAP activation by IL- 6 has also been reported in human 
colorectal cancer cells.37 It is therefore plausible that the IL- 6- 
GP130- YAP pathway becomes activated in multiple disorders, 
possibly as a general response to abnormal contexts jeopardising 
organ/tissue homeostasis.
Snail was previously reported to be highly expressed in RA 
synovium and SF, and its lentiviral vector- mediated silencing 
in the joint ameliorated collagen- induced arthritis in rats.34 We 
describe the formation of a complex between Yap and Snail in SF 
from AIA mice and patients with RA. This complex was reported 
to occur in skeletal stem cells to modulate their physiological 
functions of self- renewal and lineage commitment,38 suggesting 
cell- specific and context- dependent functions of the Yap–Snail 
complex. Silencing of Yap was sufficient to prevent the invasive 
phenotype induced by Snail overexpression, demonstrating a 
requirement for active Yap to mediate SF invasiveness. Intrigu-
ingly, while Snail was reported to regulate the TNF-α-medi-
ated activation of SF,34 in our study activation of Yap occurred 
downstream of IL- 6 only, not TNF-α. Altogether, these findings 
Figure 6 Inducible ablation of Yap in Pdgfrα- expressing fibroblasts reduces inflammatory arthritis severity. Adult Yapfl/fl (Yap WT) or Pdgfrα-
CreER;Yapfl/fl (Yap ciKO) mice received tamoxifen to activate Cre and KO Yap, prior to induction of AIA in one knee, with the contralateral knee serving 
as control. Histological analysis was performed 9 days after arthritis induction. See online supplemental table 3 for mouse genotypes, sex and age. 
(A) Yap expression in the inflamed synovium detected by IHC with haematoxylin counterstain. Histological images were selected from the same mice 
as shown in panel (C). Boxed areas in images on the left are shown at higher magnification on the right. Scale bars: 50 µm. For isotype negative 
control staining, see online supplemental figure 10f. (B) Yap expression in synovium, based on IHC staining intensity. P value indicates result of 
two- tailed unpaired t- test (WT: n=9; ciKO n=6; pooled data from two experiments). (C) Synovitis and erosive damage in AIA knees detected by H&E 
staining. Images show matched control and AIA knees from female mice in the same experiment with arthritis scores (WT: 5.00; ciKO: 2.99) close 
to the average of their respective groups. Boxed areas in images on the left are shown at higher magnification on the right. Scale bars: 200 µm. (D) 
Histological assessment of severity of synovial hyperplasia, immune infiltrates, cellular exudate and marginal erosions (all on scale 0–3), and overall 
arthritis severity (scale 0–12). P values indicate results of Mann- Whitney U test (WT: n=9; ciKO: n=6, pooled data from two experiments). Lines and 
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configure a synergistic cooperation of the inflammatory cytokine 
network in RA to activate SF and transform them into destruc-
tive cells via inducing Yap–Snail interaction.
A recent study reported functionally distinct fibroblast subsets 
in RA synovium, with destructive fibroblasts restricted to the 
synovial lining layer and immune effector fibroblasts located 
in the synovial sub- lining.2 In our study, we show that while in 
normal knee joint synovium the Gdf5- lineage SF were largely 
confined to the synovial lining, as previously reported,5 in AIA 
synovitis the Gdf5- lineage SF underwent extensive proliferation 
Figure 7 IL- 6 activates Yap through Jak and drives SF invasion by stimulating Yap–Snail interaction. (A) IL- 6 activates Yap. Yap–Tead GFP reporter 
cells were stimulated with 10 ng/mL TNF-α, 10 ng/mL IL- 1β or 20 ng/mL IL- 6/sIL6R, and GFP expression was quantified by flow cytometry (n=4–6 
experiments). P value: one- way repeated measures ANOVA with Tukey’s post- test, performed on data before normalisation. (B) The Jak inhibitor 
baricitinib prevents IL- 6- induced Yap activation. Yap–Tead GFP reporter cells were treated with IL- 6/sIL6R (20 ng/mL) and baricitinib (1 or 2 µM) for 
48 hours under vehicle- controlled conditions, and GFP expression was quantified by flow cytometry (n=4 experiments). P values: one- way repeated 
measures ANOVA with Tukey’s post- test, performed on data before normalisation. (C) Baricitinib prevents IL- 6/sIL6R- induced Stat3 phosphorylation. 
Yap–Tead GFP reporter cells were pretreated for 1 hour with baricitinib (10 µM) and then treated with IL- 6/sIL6R (140 ng/mL) for 30 min, as indicated, 
under vehicle- controlled conditions. Data are representative of n=3 experiments. See online supplemental figure 11 for uncropped Western blot 
images. (D) IL- 6/sIL6R treatment (10 ng/mL) does not affect Yap mRNA expression in AIA- SF after 24 hours. (E) Yap KD prevents the increased AIA- SF 
invasiveness after IL- 6/sIL6R treatment (10 ng/mL) for 48 hours. Dots are colour- coded to indicate five independent experiments using cells from four 
different mice. P values: one- way repeated measures ANOVA with Tukey’s post- test. (F) Yap KD prevents the increased invasion of AIA- SF induced 
by Snail overexpression. Dots are colour- coded to indicate four independent experiments using cells from three different mice. P values: one- way 
repeated measures ANOVA with Tukey’s post- test. (G) Treatment with IL- 6/sIL6R (5 ng/mL) for 4 hours increased Yap–Snail complex formation in 
mouse SF, detected using proximity ligation assay. Transfection with constitutively active YAP- S127A was used as a positive control. Dots are colour- 
coded to indicate independent experiments using cells from different mice (n=4). P values: repeated measures one- way ANOVA with Dunnet’s post- 
test. Scale bars: 20 µm. (H) Treatment with IL- 6/sIL6R (5 ng/mL) for 4 hours increased YAP–SNAIL complex formation in human SF, detected using 
proximity ligation assay. Dots are colour- coded to indicate independent experiments using cells from different donors (n=3). P value: two- tailed paired 
Student’s t- test. Scale bars: 20 µm. Lines and error bars on all graphs indicate mean±SD. ANOVA, analysis of variance; IL, interleukin; KD, knockdown; 
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and expansion throughout the synovium, indicating a derange-
ment of the anatomical segregation of fibroblast lineages 
during synovitis. Our findings show the Gdf5- lineage SF to 
become erosive and support a role for Yap in the destructive 
SF, possibly through modulation of MMP expression.28–30 The 
reduced immune cell infiltrates in the synovium of Yap cKO mice 
with AIA suggests that the Gdf5- lineage also includes immune 
effector SF and that Yap may be needed in these cells to sustain 
inflammation. Indeed, Gdf5- lineage SF from Yap cKO AIA mice 
displayed reduced expression levels of IL- 34, an inflammatory 
cytokine produced by RA- SF able to support osteoclastogenesis39 
and reported to be associated with synovitis severity in patients 
with RA.40
In summary, we report a novel IL- 6- Jak- Yap–Snail signalling 
axis linking immune- mediated inflammation with pathogenic 
SF in RA. Our findings position Yap in RA- SF at the crossroads 
between the activated immune system and their destructive 
phenotype, and suggest Yap for SF- targeted therapy in RA.
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